Downregulation of ACMSD expression, commonly observed in gliomas, leads to a significant shift in metabolic flux toward QUIN and nicotinamide adenine dinucleotide (NAD+) synthesis pathways (Moffett et al., 2020; Dhuguru et al., 2023; Huang et al., 2025). Here, ACMSD is linked to central nervous system cancer.